20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION
#7202Stable Dual Variable Domain Immunoglobulin Protein Formulations
#7203Methods for reducing migraine frequency in a subject in need thereof
#7204Immunoglobulins and uses thereof
#7205Albumin-binding prodrugs of auristatin E derivatives
#7206Modulation of extracellular vesicles with electrical stimulation
#7207SYSTEMS, DEVICES, FORMULATIONS AND METHODS FOR CONTROLLED DRUG DELIVERY
#7208Composition comprising catalase, preparation method and use thereof and method for killing tumor cells
#7209Saposin C pharmaceutical compositions and methods of treating cancer
#7210LIQUID IL-1 BETA ANTIBODY FORMULATION HAVING PH OF 5.5 TO 7.0
#7211METHOD OF TREATING DEPRESSION
#7212INJECTABLE BOTULINUM TOXIN FORMULATIONS AND METHODS OF USE THEREOF HAVING HIGH RESPONSE RATE AND LONG EFFECT DURATION
#7213Long-Acting Formulations of Insulin
#7214Compositions and methods for enhancing neuro-repair
#7215Chloride salt of TAT-NR2B9C
#7216Herbal formulations of carnivorous plants and methods for treating inflammation
#7217Dialysis solution, formulated and stored in two parts, comprising phosphate
#7218Pentosan polysulfate and medicine containing pentosan polysulfate
#7219POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF
#7220Methods of treating cancer using PRMT5 inhibitors
#7221COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROINFLAMMATORY DISEASE, CONTAINING PROTEIN TYROSINE PHOSPHATASE
#7222Methods of treating residual lesions of vascular anomalies
#7223Methods for inducing pupil dilation
#7224METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS
#7225P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
#7226TRIPLET THERAPIES OF HDAC INHIBITORS, PD-L1 AND/OR PD-1 INHIBITORS, AND CTLA-4 INHIBITORS
#7227DEPOT FORMULATIONS
#7228Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
#7229LOCAL AND REGIONAL ANESTHESIA AND ANALGESIA
#7230Pharmaceutical combinations for the treatment of cancer
#7231Use of Kv11.1 channel inhibitors for treatment of pulmonary hypertension
#7232Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
#7233Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method
#7234POLY(ETHYLENE GLYCOL)-BLOCK-POLY (PROPYLENE SULFIDE) NANOCARRIER PLATFORM FOR ENHANCED EFFICACY OF IMMUNOSUPPRESSIVE AGENTS
#7235Emulsion formulations of an NK-1 receptor antagonist and uses thereof
#7236INTRAVENOUS ADMINISTRATION OF TRAMADOL
#7237INTRAVENOUS ADMINISTRATION OF TRAMADOL
#7238Umbilical cord mesenchymal stem cells (MSCs) and culture method and application thereof
#7239Nicotine-binding antibodies
#7240Formulation for anti-α4β7 antibody
#7241DOSING OF BISPECIFIC T CELL ENGAGER
#7242METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR
#7243HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE
#7244COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY AND DEGENERATIVE DISORDER
#7245Compositions for Regenerating Defective or Absent Myocardium
#7246Pegylated carfilzomib compounds
#7247MONODISPERSE RESORBABLE POLYESTER POLYMER COMPOSITIONS, SYSTEMS, AND METHODS
#7248Liquid composition containing pradofloxacin
#7249Intradermal combination vaccine against mycoplasma and porcine circovirus
#7250Stabilized liquid and lyophilized ADAMTS13 formulations
#7251Lysin polypeptides active against Gram-negative bacteria
#7252Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
#7253PTH PRODRUGS
#7254USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
#7255TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#7256TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#7257Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
#7258Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation
#7259Polynucleotides encoding interleukin-12 (IL12) and uses thereof
#7260Composition comprising an algal proteoglycan extract and use thereof
#7261Treatment of warts
#7262Composition for treating atopic dermatitis
#7263COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS
#7264Combination therapy for treatment of brain cancers
#7265Umbilical Cord Artery Perivascular Stem Cell Injection Solution for Treating Ischemic Diseases and Preparation Method Thereof
#7266Fibroblast therapy for treatment of Duchenne muscular dystrophy
#7267USE OF CEREBROLYSIN
#7268ELIMINATION OF CD19-POSITIVE LYMPHOID MALIGNANCIES BY CD19-CAR EXPRESSING NK CELLS
#7269miR29 MIMICS FOR THE TREATMENT OF OCULAR FIBROSIS
#7270USE OF ANDROGEN FOR TREATING GASTROINTESTINAL DISORDERS
#7271NANOCARRIERS AND THEIR PROCESSING FOR DIAGNOSTICS AND THERAPEUTICS
#7272TREATMENT OF GLIOMAS USING ORGANONITRO COMPOUND COMBINATION THERAPY
#7273VETERINARY ANTIPROLACTINIC COMPOSITION
#7274Dantrolene and analogs thereof for the chronic treatment and prevention of dyssynchronous cardiac dysfunction
#7275Water soluble formulation
#7276Pre-filled syringe
#7277Magnetic assisted drug delivery
#7278Bioerodible polyester polymer axitinib ocular implants and related methods of use
#7279Applications and formulations of optimized, modified human embryonic fertility culture media with biguanides and/or functional equivalents
#7280Systems and Methods for Using Improved Contrast Agent in Performing and MRI
#7281Acute Respiratory Distress Syndrome Therapeutic Agent
#7282Encapsulated adipose-derived stem cells, methods for preparation and theraputic use
#7283Immunostimulatory agonistic antibodies for use in treating cancer
#7284Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
#7285STABILIZED FORMULATIONS CONTAINING ANTI-ANGPTL3 ANTIBODIES
#7286Antibodies recognizing tau
#7287High concentration anti-C5 antibody formulations
#7288Modified cyclic dinucleoside compounds as sting modulators
#7289Crystal form of urate transporter 1 inhibitor and preparation method and use thereof
#7290ALKOXYCARBONATE ESTER PRODRUGS FOR USE AS ANTIMALARIAL AGENTS
#7291Compounds and compositions for targeting brain injuries and methods of use thereof
#7292FORMULATIONS OF BENDAMUSTINE
#7293POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING
#7294CHIKV RNA vaccines
#7295ZIKA VIRUS MRNA VACCINES
#7296Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
#7297USE OF IGF-1 IN THE PREPARATION OF MEDICAMENTS FOR PREVENTING AND/OR TREATING LIVER TUMORS
#7298TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#7299Methods of treating viral infection with a composition comprising IL-18 and IL-22
#7300METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE
#7301Ready-to-use bivalirudin compositions
#7302Platform for generating safe cell therapeutics
#7303PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#7304LONG-ACTING INJECTABLE FORMULATIONS AND USE THEREOF
#7305Abiraterone prodrugs
#7306Stable formulations for parenteral injection of small molecule drugs
#7307Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors
#7308METHODS AND COMBINATION THERAPY TO TREAT CANCER
#7309METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS
#7310PARTICLES
#7311Nucleic Acid-Based Therapy of Muscular Dystrophies
#7312Aqueous formulation for insoluble drugs
#7313USE OF SINGLE-STRANDED ANTISENSE OLIGONUCLEOTIDE IN PREVENTION OR TREATMENT OF GENETIC DISEASES INVOLVING A TRINUCLEOTIDE REPEAT EXPANSION
#7314OLIGONUCLEOTIDES FOR TISSUE SPECIFIC APOE MODULATION
#7315Modulating apolipoprotein (a) expression
#7316DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#7317ANTI-FLT-1 ANTIBODIES IN TREATING BRONCHOPULMONARY DYSPLASIA
#7318IgG Fc variants for veterinary use
#7319Lyophilized formulation of a monoclonal antibody against transthyretin
#7320IL-22 Fc FUSION PROTEINS AND METHODS OF USE
#7321Compounds for selective disruption of protein-protein interactions
#7322Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
#7323COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES
#7324Perfusion system
#7325Pharmaceutical compositions for the treatment of postoperative pain
#7326Nanocapsule-based ocular therapy
#7327Zika vaccines and immunogenic compositions, and methods of using the same
#7328Compositions and Methods for Treating Cancer with Arginine Depletion and Immuno Oncology Agents
#7329INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS
#7330Human alpha-galactosidase variants
#7331Human alpha-galactosidase variants
#7332PTH PRODRUGS
#7333Use of mRNAs encoding OX40L, IL-23 and IL-36gamma in combination with immune checkpoint blockade for treating particular cancers
#7334Compositions and methods for treating motor neuron diseases
#7335Composition comprising an algal proteoglycan extract and use thereof
#7336Preservation of pancreatic islet grafts in the extrahepatic space
#7337CHIMERIC ANTIGEN RECEPTOR, NKG2D CAR-NK CELLS EXPRESSING THE CHIMERIC ANTIGEN RECEPTOR, AND PREPARATION AND APPLICATION THEREOF
#7338Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
#7339Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections
#7340Inhibitors of human immunodeficiency virus replication
#7341Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
#7342Treatment of Breast Cancer with Liposomal Irinotecan
#7343TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE OR PREVENT ANAPHYLAXIS IN RESPONSE TO A NON-ALLERGENIC ANTIGEN
#7344ADMINISTRATION OF MONOBACTAM FOR THE TREATMENT OF URINARY TRACT INFECTION
#7345CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
#7346Prevention, treatment and reversal of disease using therapeutically effective amounts of dicarboxylic acid compounds
#7347Methods and compositions for treatment of pain using capsaicin
#7348Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
#7349Ketamine formulation for subcutaneous injection
#7350Pharmacological prophylactics against stress-induced affective disorders in females
#7351Suppression of Cytokine Release and Cytokine Storm
#7352Pharmaceutical compositions containing mixed polymeric micelles
#7353O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#7354Fulvestrant formulations and methods of their use
#7355INJECTABLE PHARMACEUTICAL COMPOSITION CONTAINING MELOXICAM, AND PREPARATION METHOD THEREFOR
#7356Soluble honokiol derivatives
#7357MODIFIED RAAV CAPSID PROTEIN FOR GENE THERAPY
#73585-halouracil-modified microRNAs and their use in the treatment of cancer
#7359Methods for differentiating mesenchymal stem cells
#7360Chimeric small molecules for the recruitment of antibodies to cancer cells
#7361Methods for treating cancer
#7362Polynucleotides encoding relaxin
#7363GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY
#7364MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
#7365HMGB1 antagonist treatment of acute lung injury
#7366Autotaxin inhibitors and uses thereof
#7367ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#7368Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof
#7369Methods for treating heart failure using glucagon receptor antagonistic antibodies
#7370PHARMACEUTICAL COMPOSITIONS, METHODS FOR PREPARATION COMPRISING SIZING OF LIPID VESICLE PARTICLES, AND USES THEREOF
#7371Collagen peptide-based medicament compositions and devices and methods of production and use thereof
#7372COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 IN COMBINATION WITH IMMUNE CHECK-POINT PATHWAY INHIBITORS
#7373Methods of CD40 and toll like receptor immune activation
#7374Compositions and methods for treatment of GCASE related disease states
#7375Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
#7376Prevention and/or treatment of hearing loss or impairment
#7377HMGB1 antagonist treatment of diabetic peripheral neuropathy
#7378Visco-supplement compositions, and methods of use thereof
#7379CADAVERIC DERIVED WOUND TREATMENT AND METHOD OF USE
#7380Therapy For Myotonic Dystrophy Type 1 Via Genome Editing of the DMPK Gene
#7381PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE, CONTAINING, AS ACTIVE INGREDIENTS, CYCLODEXTRIN AND STEM CELLS IN WHICH VEGF IS OVEREXPRESSED
#7382PHARMACEUTICAL COMPOSITION FOR TREATING CARDIAC HYPERTROPHY
#7383Bi-functional co-polymer use for ophthalmic and other topical and local applications
#7384HYPOMETHYLATING AGENTS FOR USE IN TREATMENT OF CANCER
#7385Antitumor agent for biliary tract cancer and method for treating biliary tract cancer
#7386INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
#7387Unit dose pharmaceutical of a dry powder of one or more glucocorticoid or mineralocorticoid fludrocortisone acetate and/or triamcinolone acetonide comprised in a syringe
#7388Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
#7389Steroidal hormones for the treatment and prevention of wave burst arrhythmia
#7390Linezolid formulations
#7391Multikinase inhibitors and uses in prostatic hyperplasia and urinary track diseases
#7392SUSTAINED RELEASE BUPRENORPHINE MICROSPHERES (SRBM) AND METHODS OF USE THEREOF
#7393TREATMENT OF SIDE EFFECTS OF BOTULINUM THERAPIES
#7394METHODS OF TREATING HYPERTENSION WITH ACTIVATORS OF TIE-2
#7395Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current
#7396Peptide pharmaceuticals for treatment of NASH and other disorders
#7397HMGB1 antagonist
#7398Methods and compositions for diagnosing and treating glaucoma
#7399Composition for treating joint disease and kit containing same
#7400Composition and method for reducing joint pain associated with hemarthrosis and hemophilic arthropathy
#7401METHOD FOR MANUFACTURING PREPARATION FOR INJECTION
#7402TIE2 RECEPTOR ACTIVATION FOR GLAUCOMA
#7403Methods and compositions for in vivo gene editing based cell-type-specific cellular engineering
#7404Production of Biosimilar Ustekinumab In CHO Cells
#7405Compounds for treating Rac-GTPase mediated disorder
#7406Compounds and their use for reducing uric acid levels
#7407ORGAN DIRECTED GENE DELIVERY
#7408Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
#7409Methods and compositions for treating glioma and medulloblastoma brain tumors using the zika virus
#7410TREATMENT OF CNS LYMPHOMA AND SYSTEMIC LYMPHOMA WITH INTRACEREBROVENTRICULARLY ADMINISTERED CD19 CAR
#7411Method of treating glioblastoma multiforme
#7412Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions
#7413Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration
#7414Treatment Regimens
#7415Methods for treating pulmonary non-tuberculous mycobacterial infections
#7416Methods for treating pain associated with sickle cell disease
#7417USE OF FENOLDOPAM FOR THE TREATMENT OF HEMOLYTIC UREMIC SYNDROME
#7418Compositions, devices, and methods for treating or preventing headaches
#7419MORPHINE FORMULATIONS
#7420Ligands of the mu, kappa, and delta opioid receptors
#7421Methods and compositions utilizing RRx-001 combination therapy for radioprotection
#7422METHODS AND COMPOSITIONS UTILIZING RRx-001 FOR RADIOPROTECTION
#7423Compositions and formulations including cabazitaxel and human serum albumin
#7424TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES
#7425Neuroquiescence—a treatment for neurodevelopmental and neurodegenerative bioelectrical dysregulation and demyelination
#7426Compositions of dimethyl trisulfide (DMTS) as a cyanide antidote
#7427EDDS CHELATED NANOCERIA WITH CATALASE-LIKE ACTIVITY
#7428METHODS AND COMPOSITIONS FOR TREATING CANCER USING EXOSOMES-ASSOCIATED GENE EDITING
#7429Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
#7430SUSPENSION COMPOSITIONS OF MULTI-TARGET INHIBITORS
#7431Methods for predicting drug responsiveness in cancer patients
#7432ASSAYS AND METHODS FOR DETERMINING EXPRESSION OF THE LECT2 GENE
#7433Subcutaneous formulations of anti-CD38 antibodies and their uses
#7434Antibody fusion protein and related compositions for targeting cancer
#7435Method of treating osteoarthritis with an antibody to NGF
#7436Tolerogenic DNA vaccine
#7437Peptide analogs
#7438COMPOSITIONS AND METHODS FOR ENHANCING VISUAL FUNCTION
#7439Prodrugs of a CDK inhibitor for treating cancers
#7440Compounds and their use for reducing uric acid levels
#7441METHOD FOR PREPARING LIPOSOME
#7442EXTRACTION OF STEM CELLS FROM BONE MARROW NICHES
#7443Lipid nanoparticle compositions and methods for mRNA delivery
#7444SODIUM CHLORIDE SOLUTION FOR DRUG RECONSTITUTION OR DILUTION
#7445PHARMACEUTICAL COMPOSITIONS COMPRISING 0.25 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#7446Method of treating a localized fibrotic disorder using an IL-33 antagonist
#7447Treatment of Alzheimer's Disease (AD) with an aluminum salt
#7448METHODS AND COMPOSITIONS RELATING TO P62 FOR THE TREATMENT AND PROPHYLAXIS OF CANCER
#7449Functionalized microbubble embodiments for ultrasound-mediated treatment and methods of making and using the same
#7450THERAPEUTIC DOSING OF A NEUREGULIN OR A FRAGMENT THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE
#7451Composition comprising an algal proteoglycan extract and use thereof
#7452ANAEROBIC ANTIOXIDANT COMPOSITION
#7453SUBCUTANEOUS INJECTION FORMULATION FOR REDUCING BODY WEIGHT AND USES THEREOF
#7454ENCAPSULATED CANNABINOID FORMULATIONS FOR TRANSDERMAL DELIVERY
#7455ENCAPSULATED CANNABINOID FORMULATIONS FOR ORAL DELIVERY
#7456Gene therapies for lysosomal disorders
#7457MUSCLE TREATMENT METHOD USING MYOD MUTANT
#7458COMPOSITIONS AND METHODS FOR THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AND TREATMENT OF INHERITED METABOLIC DISORDERS
#7459Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
#7460MODIFIED IMMUNE-MODULATING PARTICLES
#7461Methods for treating hepatitis B infection
#7462Methods for treating hepatitis B infection
#7463Use of chlorogenic acid in preparation of drug for treating chordoma
#7464Composition and method for treating, relieving or preventing neuropathic pain, containing choline alfoscerate as active ingredient
#7465Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions
#7466Method and composition for treating mental disorder and pain associated with nerve damage
#7467INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LMPTP) AND USES THEREOF
#7468FORMULATIONS, SYSTEMS, AND METHODS FOR THERAPEUTIC TREATMENT
#7469Compositions and methods for treating neurological disorders
#74702-iminobiotin for use in the treatment of brain cell injury
#7471TREATMENT OF CHOLANGIOCARCINOMA WITH TPCS-2A INDUCED PHOTOCHEMICAL INTERNALISATION OF GEMCITABINE
#7472Sensorineural hair cell differentiation
#7473Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
#7474Lipid nanoparticles for delivering modified RNA encoding a VEGF-A polypeptide
#7475Treating microvascular dysfunction
#7476INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES
#7477INTRAVENOUS ADMINISTRATION OF TRAMADOL
#7478COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
#7479Use of p38 inhibitors to reduce expression of DUX4
#7480Lipid analogs and liposomes comprising same
#7481Preparations and methods for treating a GD2 positive cancer
#7482Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)
#7483Anti-CD73 antibodies and uses thereof
#7484Methods for modulating an immune response
#7485Targeted radiotherapy chelates for in situ immune modulated cancer vaccination
#7486Nanoparticles for cancer therapy and diagnosis
#7487Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
#7488Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone
#7489METHODS AND COMPOSITIONS FOR PRE-EMPTIVE TREATMENT OF GRAFT VERSUS HOST DISEASE
#7490METHOD TO MANUFACTURE A STABLE PROTEIN
#7491USES OF PD-1/PD-L1 INHIBITORS AND/OR CTLA-4 INHIBITORS WITH A BIOLOGIC CONTAINING MULTIPLE CYTOKINE COMPONENTS TO TREAT CANCER
#7492Methods for administering STING agonists
#7493Compositions and methods of treating cancer using lipid agonists and receptors thereof
#7494Method of Treating a Child with Central Precocious Puberty using an Extended Release Composition
#7495Nutritional support for animals via administration of an algal derived supplement
#7496TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY
#7497T cells surface-loaded with immunostimulatory fusion molecules and uses thereof
#7498Method for tissue regeneration using cancer cell-derived exosomes
#7499Relocation of Stem Cells
#7500COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION